Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Identification of tuberculosis-associated proteins in whole blood supernatant

Authors: Takahiro Tanaka, Shinsaku Sakurada, Keiko Kano, Eri Takahashi, Kazuki Yasuda, Hisashi Hirano, Yasushi Kaburagi, Nobuyuki Kobayashi, Nguyen Thi Le Hang, Luu Thi Lien, Ikumi Matsushita, Minako Hijikata, Takafumi Uchida, Naoto Keicho

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Biological parameters are useful tools for understanding and monitoring complicated disease processes. In this study, we attempted to identify proteins associated with active pulmonary tuberculosis (TB) using a proteomic approach.

Methods

To assess TB-associated changes in the composition of human proteins, whole blood supernatants were collected from patients with active TB and healthy control subjects. Two-dimensional difference gel electrophoresis (2D-DIGE) was performed to analyze proteins with high molecular weights (approximately >20 kDa). Baseline protein levels were initially compared between patients with active TB and control subjects. Possible changes of protein patterns in active TB were also compared ex vivo between whole blood samples incubated with Mycobacterium tuberculosis (Mtb)-specific antigens (stimulated condition) and under unstimulated conditions. Immunoblot and enzyme-linked immunosorbent assays (ELISA) were performed to confirm differences in identified proteins.

Results

Under the baseline condition, we found that the levels of retinol-binding protein 4 (RBP4), fetuin-A (also called α-HS-glycoprotein), and vitamin D-binding protein differed between patients with active TB and control subjects on 2D gels. Immunoblotting results confirmed differential expression of RBP4 and fetuin-A. ELISA results further confirmed significantly lower levels of these two proteins in samples from patients with active TB than in control subjects (P < 0.0001). Mtb-specific antigen stimulation ex vivo altered clusterin expression in whole blood samples collected from patients with active TB.

Conclusions

We identified TB-associated proteins in whole blood supernatants. The dynamics of protein expression during disease progression may improve our understanding of the pathogenesis of TB.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: Global Tuberculosis Control: Epidemiology, Strategy, Financing. Geneva. 2009, WHO Press, 7-13. WHO: Global Tuberculosis Control: Epidemiology, Strategy, Financing. Geneva. 2009, WHO Press, 7-13.
2.
go back to reference Jacobsen M, Repsilber D, Guschmidt A, et al: Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med. 2007, 85: 613-621. 10.1007/s00109-007-0157-6.CrossRefPubMed Jacobsen M, Repsilber D, Guschmidt A, et al: Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med. 2007, 85: 613-621. 10.1007/s00109-007-0157-6.CrossRefPubMed
3.
go back to reference Mistry R, Cliff JM, Clayton CL, et al: Gene expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis. 2007, 195: 357-365. 10.1086/510397.CrossRefPubMed Mistry R, Cliff JM, Clayton CL, et al: Gene expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis. 2007, 195: 357-365. 10.1086/510397.CrossRefPubMed
4.
go back to reference Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S: Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006, 368: 1012-1021. 10.1016/S0140-6736(06)69342-2.CrossRefPubMed Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S: Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006, 368: 1012-1021. 10.1016/S0140-6736(06)69342-2.CrossRefPubMed
5.
go back to reference Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G: Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med. 2009, 9: 21-10.1186/1471-2466-9-21.CrossRefPubMedPubMedCentral Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G: Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med. 2009, 9: 21-10.1186/1471-2466-9-21.CrossRefPubMedPubMedCentral
6.
go back to reference Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375: 1920-1937. 10.1016/S0140-6736(10)60359-5.CrossRefPubMed Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375: 1920-1937. 10.1016/S0140-6736(10)60359-5.CrossRefPubMed
7.
go back to reference Toda T, Sugimoto M, Omori S, Matsuzaki T, Furuichi Y, Kimura N: Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization. Electrophoresis. 2000, 21: 1814-1822. 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.0.CO;2-#.CrossRefPubMed Toda T, Sugimoto M, Omori S, Matsuzaki T, Furuichi Y, Kimura N: Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization. Electrophoresis. 2000, 21: 1814-1822. 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.0.CO;2-#.CrossRefPubMed
8.
go back to reference Saeki K, Yasugi E, Okuma E, Breit SN, Nakamura M, Toda T, Kaburagi Y, Yuo A: Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab. 2005, 289: E419-428. 10.1152/ajpendo.00512.2004.CrossRefPubMed Saeki K, Yasugi E, Okuma E, Breit SN, Nakamura M, Toda T, Kaburagi Y, Yuo A: Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab. 2005, 289: E419-428. 10.1152/ajpendo.00512.2004.CrossRefPubMed
9.
go back to reference Seth M, Lamont EA, Janagama HK, Widdel A, Vulchanova L, Stabel JR, Waters WR, Palmer MV, Sreevatsan S: Biomarker discovery in subclinical mycobacterial infections of cattle. PLoS One. 2009, 4: e5478-10.1371/journal.pone.0005478.CrossRefPubMedPubMedCentral Seth M, Lamont EA, Janagama HK, Widdel A, Vulchanova L, Stabel JR, Waters WR, Palmer MV, Sreevatsan S: Biomarker discovery in subclinical mycobacterial infections of cattle. PLoS One. 2009, 4: e5478-10.1371/journal.pone.0005478.CrossRefPubMedPubMedCentral
10.
go back to reference Crowle AJ, Ross EJ: Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun. 1989, 57: 840-844.PubMedPubMedCentral Crowle AJ, Ross EJ: Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun. 1989, 57: 840-844.PubMedPubMedCentral
11.
go back to reference Jersmann HP, Dransfield I, Hart SP: Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci. 2003, 105: 273-278. 10.1042/CS20030126.CrossRefPubMed Jersmann HP, Dransfield I, Hart SP: Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci. 2003, 105: 273-278. 10.1042/CS20030126.CrossRefPubMed
12.
go back to reference Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ: Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA. 1998, 95: 14429-14434. 10.1073/pnas.95.24.14429.CrossRefPubMedPubMedCentral Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ: Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA. 1998, 95: 14429-14434. 10.1073/pnas.95.24.14429.CrossRefPubMedPubMedCentral
13.
go back to reference Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005, 436: 356-362. 10.1038/nature03711.CrossRefPubMed Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005, 436: 356-362. 10.1038/nature03711.CrossRefPubMed
14.
go back to reference Dziegielewska KM, Brown WM, Deal A, Foster KA, Fry EJ, Saunders NR: The expression of fetuin in the development and maturation of the hemopoietic and immune systems. Histochem Cell Biol. 1996, 106: 319-330. 10.1007/BF02473242.CrossRefPubMed Dziegielewska KM, Brown WM, Deal A, Foster KA, Fry EJ, Saunders NR: The expression of fetuin in the development and maturation of the hemopoietic and immune systems. Histochem Cell Biol. 1996, 106: 319-330. 10.1007/BF02473242.CrossRefPubMed
15.
go back to reference Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ: Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA. 1998, 95: 14429-14434. 10.1073/pnas.95.24.14429.CrossRefPubMedPubMedCentral Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ: Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA. 1998, 95: 14429-14434. 10.1073/pnas.95.24.14429.CrossRefPubMedPubMedCentral
16.
go back to reference Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A, Scher LA, Friedman SG, Tracey KJ: Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock. 2001, 15: 181-185. 10.1097/00024382-200115030-00004.CrossRefPubMed Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A, Scher LA, Friedman SG, Tracey KJ: Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock. 2001, 15: 181-185. 10.1097/00024382-200115030-00004.CrossRefPubMed
17.
go back to reference Jersmann HP, Dransfield I, Hart SP: Fetuin/α2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond). 2003, 105: 273-278. 10.1042/CS20030126.CrossRef Jersmann HP, Dransfield I, Hart SP: Fetuin/α2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond). 2003, 105: 273-278. 10.1042/CS20030126.CrossRef
18.
go back to reference Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD: Mineral chaperones:a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med. 2008, 86: 379-389. 10.1007/s00109-007-0294-y.CrossRefPubMed Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD: Mineral chaperones:a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med. 2008, 86: 379-389. 10.1007/s00109-007-0294-y.CrossRefPubMed
19.
go back to reference Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shilipak MG: Fetuin-A and incident diabetis mellitus in older persons. JAMA. 2008, 300: 182-188. 10.1001/jama.300.2.182.CrossRefPubMedPubMedCentral Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shilipak MG: Fetuin-A and incident diabetis mellitus in older persons. JAMA. 2008, 300: 182-188. 10.1001/jama.300.2.182.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of tuberculosis-associated proteins in whole blood supernatant
Authors
Takahiro Tanaka
Shinsaku Sakurada
Keiko Kano
Eri Takahashi
Kazuki Yasuda
Hisashi Hirano
Yasushi Kaburagi
Nobuyuki Kobayashi
Nguyen Thi Le Hang
Luu Thi Lien
Ikumi Matsushita
Minako Hijikata
Takafumi Uchida
Naoto Keicho
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-71

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.